Supplmental materials for network-analyses assessing the risk of the most prevalent dermatologic adverse events among various immuno-oncology therapies for patients with melanoma

This dataset includes the following supplemental materials for the network-analyses assessing the risk of the most prevalent dermatologic adverse events among various immuno-oncology therapies for patients with melanoma: 1. Literature search strategy 2. Supplemental Fig. 1 Flowchart of trial selection 3. Supplemental Table 1. Trial characteristics 4. Supplemental Table 2. P-scores and best safety rankings for rash and pruritus in network meta-analyses